Connect with us

Business

Wilfred Co-Creator Jason Gann on His Cannabis Brand, Delta-8, and Mental Health

Published

on

The last time I caught up with Wilfred star-turned-cannabis operator Jason Gann in January 2021, he was weathering the ups and downs of startup cannabis ownership. 

Today, he’s continuing to survive, learn, and grow his brand, Wilfred CBD and Hemp, as well as his entrepreneurial acumen. While doing so, he’s taking the usual entrepreneurial smacks. In addition to steering his brand, Gann is embarking on additional endeavors to grow the brand while giving back to his fans and the cannabis community.

Wilfred Cannabis

Launched in December 2020, the Wilfred Cannabis brand came out the gate in California, highlighted by THC pre-roll smokes shaped like cigarettes. A few months later came CBD smokes rolled similarly. The THC brand began making incremental gains across the California market. Interest was quickly piqued among a loyal fan base for the Australian and U.S. versions of Wilfred, which Gann co-created. The recognition led to book meetings, appearances and sales.

Backed by marketing efforts like in-store demos–with Gann pulling half shifts as himself and half as Wilfred for meet and greets—he reported strong growth potential for the THC brand. He noted that there are plans to possibly expand into Oregon, Washington State, Michigan, and Pennsylvania.

But a double whammy of the pandemic mixed with product and partner issues dealt Wilfred a substantial setback. The growth plans stalled in time. Rather than push on, the THC brand halted in 2021.

Like many aspiring cannabis operators, Gann pivoted to stay operational. With THC efforts on hiatus, he’s focused on the CBD line and Delta-8, a sometimes controversial product offering he stands behind.

Delta-8-THC, a naturally occurring chemical cannabinoid found in small doses in hemp and marijuana plants, certainly has its endorsers and operators like Gann. Many like him support its use for a reported less intense high. Many others have championed Delta-8 for its ability to skirt prohibition laws against Delta-9-THC and be sold legally. 

Most concerns about the Delta-8 revolve around flower quality and potential spraying of solvents during production. Delta-8 proponents push back on the claim, often suggesting that only a few bad actors participate in such practices. Still, many states have placed bans or partial prohibitions on its sale and production while the debate continues. 14 states have passed laws against Delta-8 as of January 2023.

Gann said he became a fan of Delta-8 after being introduced to it during the pandemic.

“I am a big, big spokesman for Delta-8,” said Gann. He added, “It gets a real bad rap but…I’m more productive, my concentration is better and I don’t get anxiety.”

On the CBD side, Wilfred Cannabis continues to source its flower from an unnamed Tennessee-based hemp producer. Each CBD cigarette contains between 80 and 100mg of CBD. Meanwhile, the THC brand is exploring new ways to enter various US markets. Licensing deals in multiple territories, including California, Illinois, New York, and Australia, are being discussed.

Gann touched on several positives he sees in licensing, including “Partnering up with a licensed partner who sees the value in the brand, and they wanna have exclusive rights in that state.”

Now based in Galicia, Spain with his wife and children, Gann splits time between his wife’s home country and the U.S. to meet with brands, production partners, and other business operations.

Doubling Down On Podcast Plans

Podcast plans are also in the works for the Wilfred brand, with one focused on the show and another on the cannabis plant.

It’s been 21 years since Wilfred first appeared in an Australian short film. The short launched two seasons on Australian TV in 2007 and 2010. In 2011, a U.S. version premiered, spanning four seasons and 49 episodes, concluding in 2014. Along the way, the show picked up a dedicated fan following that remains active on Gann’s personal and brand Instagram accounts.

After seeing the wave of success from other nostalgia watchalongs podcasts, Gann decided to launch one for Wilfred fans. Plans are now in the works for Wilfred Dissected, where he, co-stars, and production members will watch and reminisce about episodes and days on set. He also hopes the podcast can help tap into mental health components often discussed on the show. 

“With Wilfred Dissected, there’s something of a behind the scenes reunion,” he said. “But there’s also that mental health aspect that people do reach out to me all the time for.” 

Over the years, Gann has received numerous messages and met with fans in person who have discussed how the show helped with their mental health experiences. To address this aspect, he hopes to also have mental health experts on the show. 

Gann is now refining production measures for the show. Pre-production planning is reportedly close to completion. Booking guests is almost complete as well. Gann reports most principles and select production members have signed on. He has not yet secured U.S. co-star Elijah Wood just yet, citing work schedules, but he remains optimistic it will happen.

Gann also said that discussions for a third Australian series to mark the 20th anniversary could be in the works. However, nothing is planned at this time.  

“I’m not announcing it, but we are talking about it,” he said. “It would be kinda cool to just sort of put a button on the end of it and bring it back where it started.” 

The Cannabis Code

Gann’s second planned podcast endeavor is The Cannabis Code. Billed as Cosmos meets Ancient Aliens meets The Da Vinci Code, each episode plans to feature Gann taking listeners on a journey that connects cannabis to humanity and beyond. Gann’s personal experiences with the plant, mental health and alcoholism over the years inspired the show. 

With six years of sobriety by 2013, Gann abstained from cannabis until season 4 of Wilfred was close to shooting. The decision came from understandings he’d gathered earlier in life, as well as the help of a doctor. To Gann, the decision to use cannabis was more than medical.

“I just felt like I had a spiritual relationship with cannabis that was important for my soul’s journey,” he said. 

The feeling inspired him to explore the spiritual connection cannabis has with some of humanity’s earliest groups and beyond. In The Cannabis Code, he hopes to analyze those connections and what he feels they mean.

“I believe there to be some other healing element component to cannabis that science and medicine can’t yet define,” he said. 

Gann took a particular interest in the Dogon people of Mali. Ancient Dogon stories and prophecies believe cannabis originated from the brightest star in the winter sky, the Two-Dog Star. Known as the two-dog plant to the Dogon, the plant was gifted to humans by a visiting species. The story has been passed down for thousands of years. As such, many believe the Dogon have a connection to extraterrestrial species, one which Gann supports. 

“I don’t believe these people told this story with, what a purpose of playing, like, a 20,000-year-old prank…on the future generations,” he said. 

Gann not only believes that cannabis came from another planet to help expand and evolve our thinking. He claims to have first-hand experience with out-of-this-planet beings. 

“When I was about 27 years old, I had an interaction with a conglomerate of extraterrestrial beings,” he said. 

Since that experience 23 years ago, Gann has explored extraterrestrials, histories and ancient civilizations to learn more. He feels The Cannabis Code helps answer some of those questions. 

“I’ve recently started calling myself a ‘cann-spiracy theorist’ because, for me, I think that there’s so much to this plant,” he said. 

Gann did not provide official release dates for either podcast but hopes to give some updates soon.

Source: https://hightimes.com/news/wilfred-co-creator-jason-gann-on-his-cannabis-brand-delta-8-and-mental-health/

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News